Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATBPF | BMY | AMGN | GILD | REGN |
| Company | Antibe Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5399 | 76.09 | 242.35 | 63.09 | 660.35 |
| High | 0.5500 | 76.79 | 245.86 | 63.58 | 660.62 |
| Low | 0.5399 | 75.68 | 241.86 | 62.81 | 650.82 |
| Last | 0.5500 | 75.96 | 244.77 | 63.27 | 657.15 |
| Change | +0.0203 | -1.06 | +0.81 | +0.05 | -2.05 |
| % Change | +3.83% | -1.38% | +0.33% | +0.08% | -0.31% |
| Volume | 3,000 | 14,858,801 | 2,414,100 | 8,833,500 | 607,700 |
| 20-Day Average Volume | 5,175 | 16,030,985 | 3,393,840 | 8,699,965 | 651,180 |
| Previous Close | 0.5297 | 77.02 | 243.96 | 63.22 | 659.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5504 | 76.20 | 241.46 | 61.76 | 652.18 |
| 20-Day Raw Stochastic | 35.25% | 51.03% | 61.06% | 86.28% | 53.36% |
| 20-Day Relative Strength | 47.61% | 53.42% | 53.90% | 56.35% | 48.58% |
| Weighted Alpha | -63.50 | +20.10 | +3.00 | -8.60 | +23.60 |
| Today's Opinion | 88% Sell | 80% Buy | 72% Buy | 40% Sell | 56% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 88% Buy | 40% Sell | 56% Buy |
| Last Month's Opinion | 16% Sell | 100% Buy | 100% Buy | 40% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.34% since 05/11/22 | -0.45% since 05/12/22 | +0.02% since 05/12/22 | +1.26% since 05/12/22 | +3.66% since 05/12/22 |
| Low | 0.5160 on 05/18/22 | 75.52 on 05/13/22 | 239.26 on 05/17/22 | 61.56 on 05/13/22 | 629.08 on 05/13/22 |
| High | 0.5620 on 05/12/22 | 78.46 on 05/18/22 | 247.29 on 05/18/22 | 63.92 on 05/18/22 | 672.54 on 05/18/22 |
| 1-Month | |||||
| %Chg | -11.29% since 04/19/22 | -0.58% since 04/19/22 | -3.39% since 04/19/22 | +0.78% since 04/19/22 | -8.25% since 04/19/22 |
| Low | 0.5070 on 05/11/22 | 73.35 on 04/29/22 | 227.32 on 05/02/22 | 59.15 on 05/02/22 | 597.76 on 05/09/22 |
| High | 0.6166 on 04/21/22 | 78.46 on 05/18/22 | 258.39 on 04/21/22 | 64.28 on 04/21/22 | 725.32 on 04/21/22 |
| 3-Month | |||||
| %Chg | -6.78% since 02/18/22 | +12.45% since 02/18/22 | +10.87% since 02/18/22 | +3.64% since 02/18/22 | +6.83% since 02/18/22 |
| Low | 0.5070 on 05/11/22 | 66.19 on 02/24/22 | 214.39 on 02/24/22 | 57.19 on 03/16/22 | 597.76 on 05/09/22 |
| High | 0.6720 on 03/30/22 | 78.46 on 05/18/22 | 258.45 on 04/11/22 | 64.28 on 04/21/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | -17.36% since 11/19/21 | +31.35% since 11/19/21 | +18.77% since 11/19/21 | -7.89% since 11/19/21 | +0.68% since 11/19/21 |
| Low | 0.4430 on 01/03/22 | 53.22 on 11/30/21 | 198.64 on 12/01/21 | 57.19 on 03/16/22 | 592.86 on 01/07/22 |
| High | 0.6965 on 11/23/21 | 78.46 on 05/18/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,654 | 161,723,696 | 130,756,144 | 79,360,384 | 71,326,408 |
| Shares Outstanding, K | 52,099 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 7,360,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -19,930,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 0 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -3,850,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | 0.29 | 0.49 | 0.58 | 0.38 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 02/14/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 06/27/22 | 04/29/22 | 04/27/22 | 04/28/22 | 05/04/22 |
| Most Recent Dividend | N/A | 0.540 on 03/31/22 | 1.940 on 05/16/22 | 0.730 on 03/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 03/31/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.98 | 13.81 | 8.62 | 8.39 |
